These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 38825462)

  • 1. Analysis of Metabolic Changes in Endogenous Metabolites and Diagnostic Biomarkers for Various Diseases Using Liquid Chromatography and Mass Spectrometry.
    Maekawa M
    Biol Pharm Bull; 2024; 47(6):1087-1105. PubMed ID: 38825462
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development of a Highly Sensitive and Rapid Liquid Chromatography-Tandem Mass Spectrometric Method Using a Basic Mobile Phase Additive to Determine the Characteristics of the Urinary Metabolites for Niemann-Pick Disease Type C.
    Maekawa M; Miyoshi K; Narita A; Sato T; Sato Y; Kumondai M; Kikuchi M; Higaki K; Okuyama T; Eto Y; Sakamaki H; Mano N
    Biol Pharm Bull; 2022; 45(9):1259-1268. PubMed ID: 36047194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic Alteration Analysis of Steroid Hormones in Niemann-Pick Disease Type C Model Cell Using Liquid Chromatography/Tandem Mass Spectrometry.
    Abe A; Maekawa M; Sato T; Sato Y; Kumondai M; Takahashi H; Kikuchi M; Higaki K; Ogura J; Mano N
    Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457276
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Diagnostic performance evaluation of sulfate-conjugated cholesterol metabolites as urinary biomarkers of Niemann-Pick disease type C.
    Maekawa M; Narita A; Jinnoh I; Iida T; Marquardt T; Mengel E; Eto Y; Clayton PT; Yamaguchi H; Mano N
    Clin Chim Acta; 2019 Jul; 494():58-63. PubMed ID: 30876856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Structural Determination of Lysosphingomyelin-509 and Discovery of Novel Class Lipids from Patients with Niemann-Pick Disease Type C.
    Maekawa M; Jinnoh I; Matsumoto Y; Narita A; Mashima R; Takahashi H; Iwahori A; Saigusa D; Fujii K; Abe A; Higaki K; Yamauchi S; Ozeki Y; Shimoda K; Tomioka Y; Okuyama T; Eto Y; Ohno K; T Clayton P; Yamaguchi H; Mano N
    Int J Mol Sci; 2019 Oct; 20(20):. PubMed ID: 31658747
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of diagnostic performance of five urinary cholesterol metabolites for Niemann-Pick disease type C.
    Maekawa M; Jinnoh I; Narita A; Iida T; Saigusa D; Iwahori A; Nittono H; Okuyama T; Eto Y; Ohno K; Clayton PT; Yamaguchi H; Mano N
    J Lipid Res; 2019 Dec; 60(12):2074-2081. PubMed ID: 31586016
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biomarker analysis of Niemann-Pick disease type C using chromatography and mass spectrometry.
    Maekawa M; Iwahori A; Mano N
    J Pharm Biomed Anal; 2020 Nov; 191():113622. PubMed ID: 32998104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Searching, Structural Determination, and Diagnostic Performance Evaluation of Biomarker Molecules for Niemann-Pick Disease Type C Using Liquid Chromatography/Tandem Mass Spectrometry.
    Maekawa M; Mano N
    Mass Spectrom (Tokyo); 2022; 11(1):A0111. PubMed ID: 36713801
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quantitation of plasmatic lysosphingomyelin and lysosphingomyelin-509 for differential screening of Niemann-Pick A/B and C diseases.
    Kuchar L; Sikora J; Gulinello ME; Poupetova H; Lugowska A; Malinova V; Jahnova H; Asfaw B; Ledvinova J
    Anal Biochem; 2017 May; 525():73-77. PubMed ID: 28259515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification cholesterol metabolites altered before the onset of nonalcoholic steatohepatitis by targeted metabolomics.
    Shoji S; Maekawa M; Ogura J; Sato T; Mano N
    Biochim Biophys Acta Mol Cell Biol Lipids; 2022 May; 1867(5):159135. PubMed ID: 35217199
    [TBL] [Abstract][Full Text] [Related]  

  • 11. LC/ESI-MS/MS analysis of urinary 3β-sulfooxy-7β-N-acetylglucosaminyl-5-cholen-24-oic acid and its amides: new biomarkers for the detection of Niemann-Pick type C disease.
    Maekawa M; Misawa Y; Sotoura A; Yamaguchi H; Togawa M; Ohno K; Nittono H; Kakiyama G; Iida T; Hofmann AF; Goto J; Shimada M; Mano N
    Steroids; 2013 Oct; 78(10):967-72. PubMed ID: 23751200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A combination of 7-ketocholesterol, lysosphingomyelin and bile acid-408 to diagnose Niemann-Pick disease type C using LC-MS/MS.
    Wu C; Iwamoto T; Hossain MA; Akiyama K; Igarashi J; Miyajima T; Eto Y
    PLoS One; 2020; 15(9):e0238624. PubMed ID: 32898135
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of a Diagnostic Screening Strategy for Niemann-Pick Diseases Based on Simultaneous Liquid Chromatography-Tandem Mass Spectrometry Analyses of N-Palmitoyl-O-phosphocholine-serine and Sphingosylphosphorylcholine.
    Iwahori A; Maekawa M; Narita A; Kato A; Sato T; Ogura J; Sato Y; Kikuchi M; Noguchi A; Higaki K; Okuyama T; Takahashi T; Eto Y; Mano N
    Biol Pharm Bull; 2020 Sep; 43(9):1398-1406. PubMed ID: 32581190
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Focused metabolomics using liquid chromatography/electrospray ionization tandem mass spectrometry for analysis of urinary conjugated cholesterol metabolites from patients with Niemann-Pick disease type C and 3β-hydroxysteroid dehydrogenase deficiency.
    Maekawa M; Shimada M; Ohno K; Togawa M; Nittono H; Iida T; Hofmann AF; Goto J; Yamaguchi H; Mano N
    Ann Clin Biochem; 2015 Sep; 52(Pt 5):576-87. PubMed ID: 25575700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of novel bile acids as biomarkers for the early diagnosis of Niemann-Pick C disease.
    Mazzacuva F; Mills P; Mills K; Camuzeaux S; Gissen P; Nicoli ER; Wassif C; Te Vruchte D; Porter FD; Maekawa M; Mano N; Iida T; Platt F; Clayton PT
    FEBS Lett; 2016 Jun; 590(11):1651-62. PubMed ID: 27139891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. LC-MS/MS multiplex analysis of lysosphingolipids in plasma and amniotic fluid: A novel tool for the screening of sphingolipidoses and Niemann-Pick type C disease.
    Pettazzoni M; Froissart R; Pagan C; Vanier MT; Ruet S; Latour P; Guffon N; Fouilhoux A; Germain DP; Levade T; Vianey-Saban C; Piraud M; Cheillan D
    PLoS One; 2017; 12(7):e0181700. PubMed ID: 28749998
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of niemann-pick C1 by measurement of bile acid biomarkers in archived newborn dried blood spots.
    Jiang X; Sidhu R; Orsini JJ; Farhat NY; Porter FD; Berry-Kravis E; Schaffer JE; Ory DS
    Mol Genet Metab; 2019 Feb; 126(2):183-187. PubMed ID: 30172462
    [TBL] [Abstract][Full Text] [Related]  

  • 18. High level of oxysterols in neonatal cholestasis: a pitfall in analysis of biochemical markers for Niemann-Pick type C disease.
    Polo G; Burlina A; Furlan F; Kolamunnage T; Cananzi M; Giordano L; Zaninotto M; Plebani M; Burlina A
    Clin Chem Lab Med; 2016 Jul; 54(7):1221-9. PubMed ID: 26650075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Determination of 7-ketocholesterol in plasma by LC-MS for rapid diagnosis of acid SMase-deficient Niemann-Pick disease.
    Lin N; Zhang H; Qiu W; Ye J; Han L; Wang Y; Gu X
    J Lipid Res; 2014 Feb; 55(2):338-43. PubMed ID: 24190732
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A new simple and rapid LC-ESI-MS/MS method for quantification of plasma oxysterols as dimethylaminobutyrate esters. Its successful use for the diagnosis of Niemann-Pick type C disease.
    Boenzi S; Deodato F; Taurisano R; Martinelli D; Verrigni D; Carrozzo R; Bertini E; Pastore A; Dionisi-Vici C; Johnson DW
    Clin Chim Acta; 2014 Nov; 437():93-100. PubMed ID: 25038260
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.